Cancer Moonshot Connecting International Liquid Biopsy Efforts Through Academic Partnership.
The Kuhn Laboratory at the University of Southern California and the Dive Laboratory at the Cancer Research UK's Manchester Institute are teaming up to apply new cancer cell detection technology to identify patients who will progress after initial treatment. Researchers will take a simple blood sample to identify early those patients whose cancer has returned, while analyzing circulating tumor cells (CTCs) in great detail, providing new clues on the most effective therapy for the patient's cancer.
Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.
C
C
Dive
Bridge Institute, University of Southern California, Dornsife College of Letters, Arts and Sciences, Los Angeles, California, USA.
S N
SN
Shishido
Bridge Institute, University of Southern California, Dornsife College of Letters, Arts and Sciences, Los Angeles, California, USA.
P
P
Kuhn
D001271:Atlases as Topic; D014408:Biomarkers, Tumor / Q000097:blood*; D001706:Biopsy; D023281:Genomics; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics / Q000473:pathology
D014408:Biomarkers, Tumor